Marina Pavanello

Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil

M. Ellis, R. Tamimi, S. Tsavachidis, 2022, The oncologist.

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

M. Pike, M. Beckmann, P. Fasching, 2021, Virchows Archiv.

Expression of unusual immunohistochemical markers in mucinous breast carcinoma.

L. Sarian, S. Derchain, J. Vassallo, 2017, Acta histochemica.

Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer

P. Pharoah, S. Gayther, S. Ramus, 2020, Cancers.

Role of discoidin domain receptor 2 (DDR2) and microRNA-182 in survival of women with high-grade serous ovarian cancer

L. Sarian, L. F. Sallum, S. Derchain, 2019, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.